Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Avibactam sodium + aztreonam) by AbbVie for Hospital Acquired Pneumonia (HAP): Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Hospital Acquired Pneumonia (HAP)....
(Avibactam sodium + aztreonam) by AbbVie for Ventilator Associated Pneumonia (VAP): Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Ventilator Associated Pneumonia (VAP)....
(Avibactam sodium + aztreonam) by Pfizer for Pyelonephritis: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by Pfizer and currently in Phase III for Pyelonephritis. According to GlobalData,...
(Avibactam sodium + aztreonam) by AbbVie for Bacterial Pneumonia: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Bacterial Pneumonia. According to...
(Avibactam sodium + aztreonam) by AbbVie for Complicated Intra-Abdominal Infections: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Complicated Intra-Abdominal Infections. According...
(Avibactam sodium + aztreonam) by AbbVie for Gram-Negative Bacterial Infections: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Gram-Negative Bacterial Infections. According...
(Avibactam sodium + aztreonam) by AbbVie for Urinary Tract Infections: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Urinary Tract Infections. According...
(Avibactam sodium + aztreonam) by AbbVie for Peritonitis: Likelihood of Approval
(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Peritonitis. According to GlobalData,...